Patents by Inventor Christophe Pierre Alain Chassaing

Christophe Pierre Alain Chassaing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220017499
    Abstract: The application relates to processes for the preparation of 1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl) amino]pyrazole-4-carboxamide (I) which include (i) a synthesis for bromo and iodo pyridine intermediates, (ii) a synthesis of a pyrazole ester intermediate which can be obtained in enantiopure form and (iii) the combination of these intermediates into compound (I).
    Type: Application
    Filed: December 12, 2019
    Publication date: January 20, 2022
    Applicant: Intervet Inc.
    Inventors: Christophe Pierre Alain Chassaing, Jingjun Yin, Licheng Song, Wensong Xiao, Edward Cleator, Thomas Dahmen, Daniel Salanta, Claudia Scheipers, Harald Schmitt
  • Publication number: 20210317077
    Abstract: The present disclosure encompasses crystalline forms of N1-(1-cyanocyclopropyl)-N2-((1S)-1-{4?-[(1R-2,2-difluoro-1-hydroxyethyl]biphenyl-4-yl}-2,2,2-trifluoroethyl)-4-fluoro-L-leucinamide and processes for the preparation thereof.
    Type: Application
    Filed: August 1, 2019
    Publication date: October 14, 2021
    Applicant: Intervet Inc.
    Inventors: Xiaoling Jin, Dirk Stueber, Cynthia Bazin, Rositza Iordanova Petrova, Christophe Pierre Alain Chassaing, Hans Peter Niedermann, Stephan Veit, Claudia Scheipers, Jochen Schoell
  • Publication number: 20210300863
    Abstract: A method of preparing a compound of Formula (I) comprising reacting the compound of Formula (A) with a base and a compound of Formula (B) to yield a compound of Formula (C).
    Type: Application
    Filed: August 1, 2019
    Publication date: September 30, 2021
    Applicant: Intervet Inc.
    Inventors: Eric Voight, Christophe Pierre Alain Chassaing, Hans Peter Niedermann, Stephan Veit, Claudia Scheipers
  • Publication number: 20200283389
    Abstract: An improved process for producing a compound of Formula (I).
    Type: Application
    Filed: December 22, 2016
    Publication date: September 10, 2020
    Applicant: Intervet Inc.
    Inventors: Michael Berger, Hans Peter Niedermann, Tobias Kappesser, Stephan Veit, Heiko Bothe, Marcus Knell, Christophe Pierre Alain Chassaing
  • Publication number: 20180280367
    Abstract: This invention is directed to compounds and salts that are generally useful as agents to treat an infection with Dirofilaria immitis. This invention also is directed to treatments comprising the administration of the compounds and salts to animals in need of the treatments.
    Type: Application
    Filed: June 4, 2018
    Publication date: October 4, 2018
    Applicant: Intervet Inc.
    Inventors: Christophe Pierre Alain Chassaing, Jurgen Lutz, Anja Regina Heckeroth
  • Patent number: 10010538
    Abstract: This invention is directed to compounds and salts that are generally useful as agents to treat an infection with Dirofilaria immitis. This invention also is directed to treatments comprising the administration of the compounds and salts to animals in need of the treatments.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: July 3, 2018
    Assignee: Intervet Inc.
    Inventors: Christophe Pierre Alain Chassaing, Jurgen Lutz, Anja Regina Heckeroth
  • Publication number: 20170202816
    Abstract: This invention is directed to compounds and salts that are generally useful as agents to treat an infection with Dirofilaria immitis. This invention also is directed to treatments comprising the administration of the compounds and salts to animals in need of the treatments.
    Type: Application
    Filed: July 10, 2015
    Publication date: July 20, 2017
    Applicant: Intervet Inc.
    Inventors: Christophe Pierre Alain Chassaing, Jurgen Lutz, Anja Regina Heckeroth
  • Publication number: 20170196854
    Abstract: This invention is directed to compounds and salts that are generally useful as agents to treat an infection with Dirofilaria immitis. This invention also is directed to treatments comprising the administration of the compounds and salts to animals in need of the treatments.
    Type: Application
    Filed: July 10, 2015
    Publication date: July 13, 2017
    Applicant: Intervet Inc.
    Inventors: Christophe Pierre Alain Chassaing, Jurgen Lutz, Anja Regina Heckeroth
  • Patent number: 9598412
    Abstract: This invention relates to spiroindoline compounds for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: March 21, 2017
    Assignee: Intervet Inc.
    Inventors: Jürgen Lutz, Sandra Koch, Manfred Uphoff, Anja Regina Heckeroth, Britta von Oepen, Ulrich Sondern, Christophe Pierre Alain Chassaing
  • Patent number: 9096524
    Abstract: This invention is directed to compounds and salts that are generally useful as anthelmintic agents or as intermediates in processes for making anthelmintic agents. This invention also is directed to processes for making the compounds and salts, pharmaceutical compositions and kits comprising the compounds and salts, uses of the compounds and salts to make medicaments, and treatments comprising the administration of the compounds and salts to animals in need of the treatments.
    Type: Grant
    Filed: March 17, 2010
    Date of Patent: August 4, 2015
    Assignee: Intervet International B.V.
    Inventors: Christophe Pierre Alain Chassaing, Thorsten Meyer
  • Patent number: 9096599
    Abstract: This invention relates to novel spiroindoline compounds of formula (I) that are generally useful as medicaments, more specifically as medicaments for animals. The medicament can preferably be used for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. This invention also relates to the preparation of said compounds. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.
    Type: Grant
    Filed: August 3, 2012
    Date of Patent: August 4, 2015
    Assignee: Intervet Inc.
    Inventors: Christophe Pierre Alain Chassaing, Sandra Koch, Jürgen Lutz
  • Publication number: 20150057302
    Abstract: This invention relates to spiroindoline compounds for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.
    Type: Application
    Filed: October 14, 2014
    Publication date: February 26, 2015
    Inventors: Jürgen LUTZ, Sandra KOCH, Manfred UPHOFF, Anja Regina HECKEROTH, Britta von OEPEN, Ulrich SONDERN, Christophe Pierre Alain CHASSAING
  • Publication number: 20140163056
    Abstract: This invention relates to novel spiroindoline compounds of formula (I) that are generally useful as medicaments, more specifically as medicaments for animals. The medicament can preferably be used for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. This invention also relates to the preparation of said compounds. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.
    Type: Application
    Filed: August 3, 2012
    Publication date: June 12, 2014
    Inventors: Christophe Pierre Alain Chassaing, Sandra Koch, Jürgen LUTZ
  • Patent number: 8569495
    Abstract: This invention is directed to compounds and salts that are generally useful as anthelmintic agents or as intermediates in processes for making anthelmintic agents. This invention also is directed to processes for making the compounds and salts, pharmaceutical compositions and kits comprising the compounds and salts, uses of the compounds and salts to make medicaments, and treatments comprising the administration of the compounds and salts to animals in need of the treatments.
    Type: Grant
    Filed: December 16, 2008
    Date of Patent: October 29, 2013
    Assignee: Intervet International B.V.
    Inventors: Christophe Pierre Alain Chassaing, Jörg Schröder, Thomas Simon Ilg, Manfred Uphoff, Thorsten Meyer
  • Patent number: 8507474
    Abstract: This invention is directed to compounds of the formula (I) and salts therefore that are generally useful as anthelmintic agents or as intermediates in processes for making anthelmintic agents. This invention also is directed to processes for making the compounds of this invention, pharmaceutical compositions and kits comprising the compounds of this invention, uses of the compounds of this invention to make medicaments, and treatments comprising the administration of the compounds of this invention to animals in need of the treatments.
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: August 13, 2013
    Assignee: Intervet International B.V.
    Inventors: Christophe Pierre Alain Chassaing, Thorsten Meyer
  • Publication number: 20120295931
    Abstract: This invention relates to spiroindoline compounds for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.
    Type: Application
    Filed: February 4, 2011
    Publication date: November 22, 2012
    Inventors: Jürgen Lutz, Sandra Koch, Manfred Uphoff, Anja Regina Heckeroth, Britta von Oepen, Ulrich Sonderin, Christophe Pierre Alain Chassaing
  • Publication number: 20120094981
    Abstract: This invention is directed to compounds of the formula (I) and salts therefore that are generally useful as anthelmintic agents or as intermediates in processes for making anthelmintic agents. This invention also is directed to processes for making the compounds of this invention, pharmaceutical compositions and kits comprising the compounds of this invention, uses of the compounds of this invention to make medicaments, and treatments comprising the administration of the compounds of this invention to animals in need of the treatments.
    Type: Application
    Filed: June 16, 2010
    Publication date: April 19, 2012
    Inventors: Christophe Pierre Alain Chassaing, Thorsten Meyer
  • Publication number: 20110319393
    Abstract: This invention is directed to compounds and salts that are generally useful as anthelmintic agents or as intermediates in processes for making anthelmintic agents. This invention also is directed to processes for making the compounds and salts, pharmaceutical compositions and kits comprising the compounds and salts, uses of the compounds and salts to make medicaments, and treatments comprising the administration of the compounds and salts to animals in need of the treatments.
    Type: Application
    Filed: March 17, 2010
    Publication date: December 29, 2011
    Inventors: Christophe Pierre Alain Chassaing, Thorsten Meyer
  • Patent number: 7893271
    Abstract: This invention relates to benzimidazole carbamates and (thio)carbamates corresponding to Formula I: Here, X1 and X2 are independently O or S, wherein at least one of X1 and X2 is O; Y1 and Y2 are independently O or S, wherein at least one of Y1 and Y2 is O; R1 is alkyl having from 1-4 carbon atoms; R2, R3, and R4 are independently hydrogen or a cation; R5 and R6 are independently hydrogen, halogen, alkyl (having from 1-8 carbon atoms), —OR7, —SR8, —CO—R9, —OSO2—Ar, or —S(O)R10; R7 is alkyl having from 1-8 carbon atoms; R8 is alkyl (having from 1-8 carbon atoms) or aryl; R9 is alkyl (having from 1-8 carbon atoms), cycloalkyl (having from 3-6 carbon atoms), or aryl; Ar is aryl; and R10 is alkyl (having from 1-8 carbon atoms) or aryl. The compounds generally are soluble and stable in water, and have antiparasitic (particularly anthelmintic) activity in vivo that is comparable to known water-insoluble benzimidazole carbamates (e.g., albendazole and fenbendazole).
    Type: Grant
    Filed: July 18, 2006
    Date of Patent: February 22, 2011
    Assignee: Intervet International B.V.
    Inventor: Christophe Pierre Alain Chassaing
  • Publication number: 20110021506
    Abstract: This invention is directed to compounds and salts that are generally useful as anthelmintic agents or as intermediates in processes for making anthelmintic agents. This invention also is directed to processes for making the compounds and salts, pharmaceutical compositions and kits comprising the compounds and salts, uses of the compounds and salts to make medicaments, and treatments comprising the administration of the compounds and salts to animals in need of the treatments.
    Type: Application
    Filed: December 16, 2008
    Publication date: January 27, 2011
    Applicant: INTERVET INTERNATIONAL B.V.
    Inventors: Christophe Pierre Alain Chassaing, Jörg Schröder, Thomas Simon Ilg, Manfred Uphoff, Thorsten Meyer